These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 8431000

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Platelets and diabetic vascular disease.
    Paton RC, Passa P.
    Diabete Metab; 1983 Dec; 9(4):306-12. PubMed ID: 6230270
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms underlying increased platelet reactivity in patients with peripheral arterial disease. Preliminary results.
    Reininger CB, Boeger CA, Steckmeier B, Spannagl M, Scweiberer L.
    Int Angiol; 1999 Jun; 18(2):163-70. PubMed ID: 10424375
    [Abstract] [Full Text] [Related]

  • 4. Platelets and antiplatelet therapy in patients with diabetes mellitus.
    Arjomand H, Roukoz B, Surabhi SK, Cohen M.
    J Invasive Cardiol; 2003 May; 15(5):264-9. PubMed ID: 12730635
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Targeting the use of glycoprotein IIb/IIIa antagonists--the diabetic patient.
    Meier-Ewert HK, Nesto RW.
    Rev Cardiovasc Med; 2002 May; 3 Suppl 1():S20-7. PubMed ID: 12439433
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Alterations of adenine nucleotide metabolism and function of blood platelets in patients with diabetes.
    Michno A, Bielarczyk H, Pawełczyk T, Jankowska-Kulawy A, Klimaszewska J, Szutowicz A.
    Diabetes; 2007 Feb; 56(2):462-7. PubMed ID: 17259392
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Abnormal platelet function in diabetes mellitus (author's transl)].
    Kitazawa A.
    Nihon Ronen Igakkai Zasshi; 1982 Mar; 19(2):175-82. PubMed ID: 6213799
    [No Abstract] [Full Text] [Related]

  • 13. Blood platelet reactivity and its pharmacological modulation in (people with) diabetes mellitus.
    Watala C.
    Curr Pharm Des; 2005 Mar; 11(18):2331-65. PubMed ID: 16022671
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Platelet abnormalities in myeloproliferative disorders.
    Holme S, Murphy S.
    Clin Lab Med; 1990 Dec; 10(4):873-88. PubMed ID: 2272179
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Platelet abnormalities in type 2 diabetes mellitus].
    Matadamas-Zárate C, Hernández-Jerónimo J, Pérez-Campos E, Majluf-Cruz A.
    Arch Cardiol Mex; 2009 Dec; 79 Suppl 2():102-8. PubMed ID: 20361492
    [Abstract] [Full Text] [Related]

  • 19. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR.
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.